Solta Medical Inc. has put up the company for sale amid falling profits and pressure from activist investor Voce Capital Management LLC. California-based Valeant Pharmaceuticals International will buy Solta Medical for $236 million in cash.
Tags: Valeant Pharmaceuticals International Inc
Robert Goldfarb Retires As Sequoia Shares Decline
CEO Robert Goldfarb is about to retire on March 31st and will be replaced by David Poppe. Sequoia shares plunged because of Valeant Pharmaceuticals Inc. stake.
It's tough time for Goldman Sachs to sell Concordia debt amid pharma disruption
Goldman Sachs Group Inc is facing tough time in selling $2.8 billion of debt in the wake of ongoing drug pricing controversy in the pharmaceutical industry.
Valeant to drop deal-making in near term to cut debt, boost stock
Valeant Pharmaceuticals International Inc (VRX.TO) is abandoning its growth-by-acquisitions strategy for the time being to try to reduce debt, boost its stock price and one day return to its traditional deal-making in a stronger position, people familiar with the matter told Reuters.
Actavis plans new merger approach for Allergan - sources
Actavis Plc (ACT.N) plans to approach Allergan Inc (AGN.N) again about a potential merger, as the Botox maker warms up to the possibility of a sale, people familiar with the matter said on Tuesday.
Latest News
Valeant Pharmaceuticals said it expected to save more than USD 800 million when it buys Bausch & Lomb.
The following bids, mergers, acquisitions and disposals were reported by 2200 GMT on Friday. The following bids, mergers, acquisitions and disposals were reported on Friday:- SoftBank Corp is in talks with Deutsche Telekom AG over a possible deal for T-Mobile US Inc, as the Japanese company looks for alternatives to enter the U.
1
